South Africa: TK Legislation In The New Tradition 06/10/2011 by Intellectual Property Watch 2 Comments “Ex Africa semper aliquid novi”, which can be freely translated from Latin to mean “there is always something new coming out of Africa,” said Pliny, the ancient Roman writer and scholar. Presumably then, as is the case now, the concept of “new” included an expression of sarcasm and deprecation as in “absurd, nonsensical and ridiculous.” Well, Pliny has been proved right once again, writes Prof. Owen Dean.
A Response From The Authors Of The Health Impact Fund 03/10/2011 by Intellectual Property Watch Leave a Comment In reaction to the recent IP-Watch Inside Views post “Health Impact Fund – Raising Issues of Distribution, IP Rights and Alliances,” by Sakiko Fukuda-Parr and Proochista Ariana, the authors offer a response on behalf of Incentives for Global Health (IGH), the non-profit organization that is developing the Health Impact Fund (HIF) proposal.
Clear The Way For SMEs: Lessons From Nairobi 30/09/2011 by Intellectual Property Watch Leave a Comment Penye nia, pana njia. A Swahili proverb for “when there’s a will, there’s a way,” this might well be the motto for innovative entrepreneurs the world over. Whether they’re based in Nairobi, Brussels or Silicon Valley, what matters the most to entrepreneurs is the success of their businesses. Of course, what’s “in the way” of that success can vary considerably, writes Jonathan Zuck.
Health Impact Fund – Raising Issues Of Distribution, IP Rights And Alliances 26/09/2011 by Intellectual Property Watch 1 Comment This piece raises several issues with the public health financing proposal called the Health Impact Fund. It questions the relative distribution of costs and benefits; the persistent issue of intellectual property rights; as well as a lack of alliance with existing efforts to increase innovation of and access to essential medicines for the poor.
Alto Funcionário Discute Sobre Renúncia Ao Seu Cargo Na ANVISA, No Brasil, Devido à Política Sobre Patentes 11/08/2011 by Intellectual Property Watch 2 Comments Luis Carlos Wanderley Lima, funcionário sênior responsável pela política brasileira que expressa a opinião do Ministério da Saúde no referente à análise de pedidos de patente que possam ocasionar um impacto na saúde pública, renunciou recentemente em protesto contra as modificações na mencionada política. Em uma sessão de perguntas e respostas com a Intellectual Property Watch, ele conversou com relação a sua decisão.
Promoting Caribbean Intellectual Property Law 08/08/2011 by Intellectual Property Watch 1 Comment Across the world, the Caribbean is renowned for its unique flavors in music and entertainment, its beaches, cricket, and its commonly acclaimed fun and sun. While these are well-deserved, and are sources of just pride, this common perception provides foliage which bars the examination and explanation of the real problems and needs in intellectual property in the Caribbean, writes attorney Abiola Inniss.
Getting The Most Value From Your Patent Claims 04/08/2011 by Intellectual Property Watch 2 Comments Preparing patents is both a science and an art. The science is often easy to recognize, if not always easy to understand. The art of properly expressing that science in the words of a patent claim is harder to evaluate and is more often overlooked, yet is crucial to the value of the patent, write Heather J. DiPietrantonio and Edmund J. Walsh.
A Glance At Current Patent Litigation In India 29/07/2011 by Intellectual Property Watch Leave a Comment The third amendment of Patents Act 1970, in 2005, was a major breakthrough for Indian IP practice in patents. The current crop of judicial decisions, discussed in this note, has initiated the need to have a critical mass of judicial precedents streamlining law and rules governing patent practice in India, writes Kamakhya Srivastava.
Corporate Self-Interest And Strategic Choices: Gilead Licenses To Medicines Patent Pool 21/07/2011 by Intellectual Property Watch 3 Comments Gilead’s recently announced ARV licenses to the Medicines Patent Pool, although positive in some respects, still unreasonably limit the geographical access of key middle-income countries and restrict the sourcing of APIs and products to Indian companies, meaning that both generics companies and excluded countries will need to make strategic decisions to bypass the defects in the licenses, writes Brook Baker.
Interview With Chief Judge Paul R. Michel On US Patent Reform 14/07/2011 by Intellectual Property Watch 7 Comments Chief Judge Paul R. Michel (Ret.), of the U.S. Court of Appeals for the Federal Circuit, saw hundreds of patent cases during his distinguished career and has a unique position from which to view and offer advice on efforts in the US Senate and House of Representatives to agree on changes to domestic patent law. Intellectual Property Watch recently had the opportunity to interview Judge Michel on prospects for substantive patent reform in the US, the effect on future cases involving domestic and foreign patents, likely constitutional challenges, and the “non-problem” of non-practicing entities.